These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14621970)

  • 1. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
    Saleem IY; Smyth HD
    Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
    Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
    Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
    Pu Y; Kline LC; Berry J
    Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
    Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
    Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
    Ju D; Shrimpton J; Hearn A
    Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
    Murnane D; Martin GP; Marriott C
    Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
    McCabe JC; Koppenhagen F; Blair J; Zeng XM
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
    Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
    Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.